Abbott ABT Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Abbott’s reported figures.
Based on trailing twelve months.
The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Abbott's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Abbott's return on equity?
- Abbott (ABT) reported return on equity of 12.4% in Q1 2026.
- How has Abbott's return on equity changed year-over-year?
- Abbott's return on equity decreased by 59.6% year-over-year, from 30.8% to 12.4%.
- What is the long-term trend for Abbott's return on equity?
- Over 4 years (2021 to 2025), Abbott's return on equity has grown at a 7.1% compound annual growth rate (CAGR), from 80.4% to 105.8%.
- What does return on equity mean?
- How much profit the company earns on the money shareholders have invested.
- How do you interpret return on equity?
- Higher is better, but very high ROE can be manufactured by leverage — a thin equity base inflates the ratio. Read it next to debt-to-equity and ROIC to tell genuine returns from balance-sheet engineering.
- How does return on equity compare across companies?
- Comparable across peers, with the leverage caveat. Negative or near-zero equity makes ROE meaningless, so it is suppressed there.